Once-Weekly Semaglutide in Adults With Alcohol Use Disorder
This randomized clinical trial assesses the effects of subcutaneous semaglutide on alcohol consumption in adults with alcohol use disorder.
Related Articles
Neurologist – Mountain View, CA – Mountain View, California
Palo Alto Foundation Medical Group (PAFMG) is seeking a full-time, BC/BE General Neurologist. Outpatient-based General Neurology for adult full sp…
Frontiers | Identifying P100 and N170 as electrophysiological markers for conscious and unconscious processing of emotional facial expressions
1 Department of Psychiatry, Psychotherapy and Psychosomatics, Faculty of Medicine, RWTH Aachen, Aachen, Germany 2 Institute of Neuroscience and Medicine, JARA-Institute Brain Structure Function Relationship…
Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis
This Viewpoint advocates for prompt aortic valve replacement (rather than clinical surveillance) as the default strategy for patients with asymptomatic severe aortic stenosis.
Frontiers | Associations of sleep quality and fall risk among older adult outpatients at Thai Binh Medical University Hospital, Northern Vietnam
1 Department of Traumatology, Thai Binh University of Medicine and Pharmacy, Thai Binh, Vietnam 2 Department of Traumatology, Dong Anh General Hospital, Hanoi, Vietnam 3…
Successful Implementation of a Moderator Intervention to Address Engagement and Attendance at a Virtual Residency Case Conference | Neurology® Journals
Residency programs throughout the United States have seen a remarkable transition to virtual education conferences since 2020. 1–3 Driven initially by the SARS-CoV-2 pandemic, they…
Frontiers | A critical period for paired-housing-dependent autistic-like behaviors attenuation in a prenatal valproic acid-induced male mouse model of autism
Department of Children’s Rehabilitation, Research Center of Rehabilitation Medicine in Henan, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China Autism spectrum disorder (ASD)…
New Tablet Formulation of Evrysdi for Spinal Muscular Atrophy Greenlighted by the FDA – Practical Neurology
A New Drug Application (NDA) for a tablet formulation of Evrysdi (risdiplam; Genentech, South San Francisco, CA) has been approved by the Food and Dru
Frontiers | Opioidergic tuning of social attachment: reciprocal relationship between social deprivation and opioid abuse
1 Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, United States 2 Nancy Pritzker Laboratory, Department of Psychiatry and Behavioral Sciences, Stanford University,…
Headache: The Journal of Head and Face Pain | AHS Journal | Wiley Online Library
Click on the article title to read more.
New Tablet Formulation of Evrysdi for Spinal Muscular Atrophy Greenlighted by the FDA – Practical Neurology
A New Drug Application (NDA) for a tablet formulation of Evrysdi (risdiplam; Genentech, South San Francisco, CA) has been approved by the Food and Dru